personalized medicine

LEXINGTON, Mass., May 11, 2026 Partner Therapeutics, Inc. (PTx) announced that the U.S. Food and Drug Administration (FDA) has...

PHILADELPHIA and VANCOUVER, British Columbia, May 6, 2026 BriaCell Therapeutics Corp. has received FDA clearance for its Investigational New...

HOUSTON, May 6, 2026 Diakonos Oncology Corp., a clinical-stage biotechnology company focused on next-generation cancer immunotherapies, has announced that...

HYDERABAD, India, Feb. 16, 2026 — The University of Hyderabad and MNJ Institute of Oncology & Regional Cancer Centre...

OTTAWA, November 5, 2025 — A new market report from Nova One Advisor, a subsidiary of Precedence Research, projects...

September 16, 2025 — San Diego, California Sanguine Biosciences has announced the expansion of its oncology biospecimen offerings through...